SNY - Sanofi Reports Positive Lung Cancer Data And Other News: The Good Bad And Ugly Of Biopharma
- Sanofi reports positive data for pivotal lung cancer trial.
- AstraZeneca announces positive data for Lynparza in prostate cancer.
- Amgen reports encouraging data for investigational Sotorasib.
For further details see:
Sanofi Reports Positive Lung Cancer Data, And Other News: The Good, Bad And Ugly Of Biopharma